Pacific Biosciences Of California | PACB - Ebitda


Pacific Biosciences Of California reported $-73.24M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
Agilent USD 540M 74M Sep/2025
Bruker USD 211.6M 207.4M Dec/2025
Danaher USD 2.13B 252M Dec/2025
General Electric Aerospace USD 3.04B 185M Sep/2025
Illumina USD 332M 12M Sep/2025
Myriad Genetics USD 10.3M 4.2M Sep/2025
Pacific Biosciences Of California USD -73.24M 3.12M Sep/2023
Quidel USD 153.3M 23.8M Dec/2025
Revvity USD 248.91M 48.52M Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Standard Biotools USD -16.54M 2.26M Sep/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Waters USD 380.97M 85.83M Dec/2025